1. Quality attribute considerations for chewable tablets Publication: Silver Spring, MD : Center for Drug Evaluation and Research, August 2018 Subject(s): Chemistry, PharmaceuticalDrug LiberationMasticationQuality ControlSolubilityTablets -- pharmacokineticsDrug ApprovalDrug LabelingHardnessTherapeutic EquivalencyHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Recommended statement for over-the-counter aspirin-containing drug products labeled with cardiovascular related imagery Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2017 Subject(s): AspirinDrug LabelingDrug PackagingNonprescription DrugsCardiovascular SystemHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, October 2023 Subject(s): Biological Products -- administration & dosageDrug Dosage CalculationsDrug IndustryDrug LabelingDrug PackagingGovernment RegulationInjections -- standardsPrescription Drugs -- administration & dosageProduct LabelingProduct PackagingUnited States
